Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Liquidia Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
LQDA
Nasdaq
8731
https://www.liquidia.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Liquidia Corp
Chief Medical Officer Rajeev Saggar Sells Shares of Liquidia Corp (LQDA)
- Mar 20th, 2024 5:50 am
Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA)
- Mar 20th, 2024 5:49 am
Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript
- Mar 16th, 2024 6:42 pm
Liquidia Full Year 2023 Earnings: Misses Expectations
- Mar 14th, 2024 10:34 am
Q4 2023 Liquidia Corp Earnings Call
- Mar 14th, 2024 2:54 am
Liquidia Corp (LQDA) Reports Full Year 2023 Financial Results
- Mar 13th, 2024 11:31 am
Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates
- Mar 13th, 2024 11:10 am
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
- Mar 13th, 2024 10:00 am
Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline
- Mar 7th, 2024 3:00 pm
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
- Mar 6th, 2024 11:30 am
Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates
- Feb 29th, 2024 1:40 pm
United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates
- Feb 22nd, 2024 5:22 pm
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
- Feb 21st, 2024 8:17 pm
UPDATE 3-United Therapeutics starts litigation with FDA over rival Liquidia's drug application
- Feb 21st, 2024 11:51 am
United Therapeutics, in unusual step, sues FDA over rival’s drug application
- Feb 21st, 2024 11:24 am
Strength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?
- Feb 19th, 2024 10:54 am
Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress
- Jan 30th, 2024 11:30 am
Wall Street Analysts Think Liquidia Technologies, Inc. (LQDA) Could Surge 71.41%: Read This Before Placing a Bet
- Jan 29th, 2024 2:55 pm
UPDATE 1-US FDA still reviewing Liquidia's inhaled blood pressure drug
- Jan 25th, 2024 11:25 am
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
- Jan 25th, 2024 11:00 am
Scroll